Country Profile

Poland

Poland is a significant market for Indian pharmaceutical exports — $251M in FY 2025–26, with 6.0× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $515K. The compound annual growth rate since FY2015 stands at 17.7%.

🇵🇱 $251M · 6.0× growth since FY2015 · 17.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$251M
Exports FY2025–26 DGCIS
6.0×
Growth FY2015→2026
17.7%
CAGR FY2015→2026
68%
Medicines Share
5
Product Categories Supplied
Poland is a significant market for Indian pharmaceutical exports — $251M in FY 2025–26, with 6.0× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $515K. The compound annual growth rate since FY2015 stands at 17.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $170M (67.8%) Medicine Ingredients $56.9M (22.7%) Surgical & Hospital Supplies $19.7M (7.9%) Traditional & Herbal $3.56M (1.4%) Vaccines $515K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Poland in the RBI overseas direct investment dataset (2011–2026).